Pfizer Shakes Up R&D Leadership, Streamlining Oncology Ahead Of Seagen Merger

 
• By Jessica Merrill
  
Exit door
William Pao is leaving Pfizer's R&D team • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Leadership

More from Scrip